Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Expanded CTG repeat RNA foci are abnormal nuclear aggregates formed by RNAs containing excessive CTG repeats, as seen especially in myotonic dystrophy type 1. These foci arise due to the ability of long CTG repeat tracts to fold into stable hairpin structures, recruiting various RNA-binding proteins (notably MBNL1, MBNL2, and others) and sequestering them in the nucleus. This sequestration alters normal RNA splicing, retention, and metabolism, initiating a toxic gain-of-function effect. Clinically, such foci underpin multisystem pathology in DM1 and other repeat expansion diseases. Therapeutic strategies aim to dissolve these foci or prevent their formation, including novel small molecules, antisense RNAs, and genome editing approaches.
Disruption or dissolution of RNA foci (by blocking secondary structure formation or repeat RNA-protein interactions); inhibition of toxic gain-of-function by reducing protein sequestration; genome editing to reduce CTG repeat length
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Expanded CTG repeat RNA foci.